–
Edgewise Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−43.2
FY22:
−71.7
FY23:
−114
FY24:
−159
FY25:
−191
(positive)
Change from FY21 to FY25
millions USD
FY21:
−42.9
FY22:
−71.1
FY23:
−113
FY24:
−157
FY25:
−189
(positive)
Change from FY21 to FY25
millions USD
FY21:
−42.8
FY22:
−67.6
FY23:
−100
FY24:
−134
FY25:
−168
(positive)
Change from FY21 to FY25
millions USD
FY21:
−42.8
FY22:
−67.6
FY23:
−100
FY24:
−134
FY25:
−168
All amounts in millions USD